Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof
AssigneeAmgen Inc.
InventorsChristiaan M. Saris, Sharon X. Mu, Min Xia, Thomas Charles Boone, Todd Covey
Life of this patent
Estimating the term…
Abstract
The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The inventio further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides.
Claims12
An isolated nucleic acid molecule comprising a nucleotide sequence:
- (a) as set forth in SEQ ID NO:
- 4;
- (b) encoding the polypeptide as set forth in SEQ ID NO:
- 5;
- (c) that is complementary to the nucleotide sequence of either (a) or (b).
An isolated nucleic acid molecule comprising a nucleotide sequence:
- (a) as set forth in SEQ ID NO:
- 23;
- (b) encoding the polypeptide as set forth in SEQ ID NO:
- 8;
- (c) that is complementary to the nucleotide sequence of either (a) or (b).
Dependencies are inferred from the claim text.